The role of angiotensin type 1 receptor in inflammation and endothelial dysfunction - PubMed (original) (raw)
Review
The role of angiotensin type 1 receptor in inflammation and endothelial dysfunction
Dana Skultetyova et al. Recent Pat Cardiovasc Drug Discov. 2007 Jan.
Abstract
Endothelial dysfunction plays an important role in all stages of atherosclerosis, and is characterized by an increased activity of vasoconstricting factors, proinflammatory and prothrombotic mediators. The aim of the review is to evaluate the role of angiotensin II (Ang II) and especially of angiotensin type 1 (AT1) receptor in inflammation and endothelial dysfunction. Ang II with AT(1) receptor are through several mechanisms implicated in the progression of atherosclerosis. Stimulation of AT(1) receptor increases oxidative stress especially through activation of NADH/NADPH oxidase in the vascular cells. Oxidative stress is associated with activation of the inflammatory processes. Ang II via AT(1) receptor increases expression of adhesion molecules and stimulates the induction of monocyte chemoattractant protein-1 (MCP-1). AT(1) receptor enhances the activation of nuclear factor NF-kappaB, which stimulates the production of proinflammatory cytokines. Proinflammatory cytokines on the other side may induce acute-phase response in the liver. Activation of AT(1) receptor via inducible cyclooxygenase (COX)-2 promotes biosynthesis of matrix metalloproteinases (MMPs). Ang II is implicated in the process of angiogenesis. Via AT(1) receptor takes part in the regulation of vascular endothelial growth factor (VEGF), which is one of the most angiogenic factors and stimulates the activity of endothelial progenitor cells (EPC). Recently some patents were reported discussing role of different compounds for the treatment of cardiovascular disease, renovascular disease nephropathy, peripheral vascular disease, portal hypertension and ophthalmic disorders, are cyclooxygenase-2 inhibitors.
Similar articles
- Change of concept about the regulation of angiotensin II-induced monocyte chemoattractant protein-1 production in human endothelial cells.
Castiñeiras-Landeira MI, Rodiño-Janeiro BK, Paradela-Dobarro B, Batista-Oliveira AL, Raposeiras-Roubín S, González-Peteiro M, González-Juanatey JR, Álvarez E. Castiñeiras-Landeira MI, et al. Vascul Pharmacol. 2016 May;80:20-34. doi: 10.1016/j.vph.2015.12.003. Epub 2015 Dec 31. Vascul Pharmacol. 2016. PMID: 26746853 - Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade.
Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. Dandona P, et al. J Hum Hypertens. 2007 Jan;21(1):20-7. doi: 10.1038/sj.jhh.1002101. Epub 2006 Nov 9. J Hum Hypertens. 2007. PMID: 17096009 Review. - Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress.
Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Pueyo ME, et al. Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):645-51. doi: 10.1161/01.atv.20.3.645. Arterioscler Thromb Vasc Biol. 2000. PMID: 10712386 - Angiotensin II stimulates MCP-1 production in rat glomerular endothelial cells via NAD(P)H oxidase-dependent nuclear factor-kappa B signaling.
Pan Q, Yang XH, Cheng YX. Pan Q, et al. Braz J Med Biol Res. 2009 Jun;42(6):531-6. doi: 10.1590/s0100-879x2009000600009. Braz J Med Biol Res. 2009. PMID: 19448902
Cited by
- Effects of renin-angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis.
Tergast TL, Griemsmann M, Wedemeyer H, Cornberg M, Maasoumy B. Tergast TL, et al. Sci Rep. 2023 Oct 14;13(1):17486. doi: 10.1038/s41598-023-44299-w. Sci Rep. 2023. PMID: 37838780 Free PMC article. - Epigallocatechin-3-gallate Regulates NADPH Oxidase Expression in Human Umbilical Vein Endothelial Cells.
Ahn HY, Kim CH, Ha TS. Ahn HY, et al. Korean J Physiol Pharmacol. 2010 Oct;14(5):325-9. doi: 10.4196/kjpp.2010.14.5.325. Epub 2010 Oct 31. Korean J Physiol Pharmacol. 2010. PMID: 21165332 Free PMC article. - Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension.
Ferraz LR, Moreira BC, de Queiroz GSR, Formigari RF, Esquisatto MAM, Felonato M, Alves AA, Thomazini BF, de Oliveira CA. Ferraz LR, et al. Mol Med Rep. 2019 Nov;20(5):4467-4476. doi: 10.3892/mmr.2019.10722. Epub 2019 Oct 2. Mol Med Rep. 2019. PMID: 31702037 Free PMC article. - Local angiotensin II aggravates cardiac remodeling in hypertension.
Xu J, Carretero OA, Liao TD, Peng H, Shesely EG, Xu J, Liu TS, Yang JJ, Reudelhuber TL, Yang XP. Xu J, et al. Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1328-38. doi: 10.1152/ajpheart.00538.2010. Epub 2010 Sep 10. Am J Physiol Heart Circ Physiol. 2010. PMID: 20833959 Free PMC article. - The impact of reactive oxygen species in the development of cardiometabolic disorders: a review.
Akhigbe R, Ajayi A. Akhigbe R, et al. Lipids Health Dis. 2021 Feb 27;20(1):23. doi: 10.1186/s12944-021-01435-7. Lipids Health Dis. 2021. PMID: 33639960 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous